tirzepatide compound court case Lilly seeks to intervene in compounded lawsuit Battle Continues Over Compounded GLP-1s
Description
Similar to other GLP-1 receptor agonists, gastrointestinal issues are the most common side effects of Zepbound
In October 2024, the FDA determined that the tirzepatide injection shortage (covering both Mounjaro and Zepbound) was resolved
So only remove the pen from the fridge when youre ready to start using it
Tirzepatide with niacinamide Niacinamide (vitamin B3) is sometimes added because early research suggested it might reduce injection site reactions and potentially enhance peptide stability
